All About Blistigel

Innovative medical device for administration of crushed tablets for patients suffering from swallowing disorders and for pediatric dosage forms administration.

PUBLICATION OF THE BLISTIGEL CLINICAL STUDY RESULTS

The results of the clinical evaluation of the innovative medical device Blistigel, intended for the administration of drugs to patients suffering from swallowing disorders, a study carried out at the University Hospital of Rouen under the supervision of Professor Jean Doucet, head of the geriatric department, have been presented at the annual congress of the French society of geriatrics and gerontology in Paris, from 21 to 23 Novembe.

Résultats étude clinique Blistigel au format PDF

PUBLICATION OF BLISTIGEL PATENT

The patent of the innovative medical device BLISTIGEL for the administration of crushed tablets for patients suffering from swallowing disorders has been published under No. 15 52642 on September 30, 2016.

Consultez le brevet Blistigel au format PDF

2015 NUTRID TROPHY

The BLISTIGEL project is awarded the NutriD 2015 trophy by Nutrisens, an expert in nutrition and health :

Publication on Nutrisens site

PDF Trophy Publication

USE OF BLISTIGEL

Publication on youtu.be of the movie in English language describing BLISTIGEL an innovative medical device for the administration of crushed tablets to patients suffering from dysphagia or swallowing disorders.

 

BLISTIGEL MEDICAL DEVICE

INSCB introduces BLISTIGEL, an innovative medical device for oral administration of crushed tablets intended to patients suffering from swallowing disorders.

This device improves treatment compliance, traceability, security of health workers and reduces the iatrogenic risks.
BLISTIGEL is a patented technology by INSCB and available for license.